Trodelvy

• Trodelvy® can lower white blood cell counts, increasing the risk of infections. Patients should be monitored regularly with blood tests. Report symptoms like fever, chills, or weakness immediately. Doctors may delay treatment or adjust doses to manage severe neutropenia and reduce complications.

• Severe diarrhea may occur during treatment with Trodelvy®. It can lead to dehydration and weakness if not managed early. Patients should inform their doctor at the first sign of loose stools. Anti-diarrheal medicines and fluids may be recommended to control symptoms and prevent complications.

• Some patients may experience allergic or infusion-related reactions during or after receiving Trodelvy®. Symptoms may include rash, breathing difficulty, or low blood pressure. Medical staff monitors patients during infusion, and medications may be administered to prevent or manage these reactions.

• Nausea and vomiting are common side effects of Trodelvy®. Doctors usually prescribe anti-nausea medications before treatment to help prevent discomfort. Patients should follow dietary advice and stay hydrated. Inform your doctor if symptoms become severe or difficult to control during therapy.

• Trodelvy® may harm an unborn baby if used during pregnancy. Women should avoid becoming pregnant during treatment and use effective contraception. If pregnancy occurs, inform the doctor immediately. Treatment decisions will be carefully evaluated to protect both the patient and the developing fetus.

• It is not recommended to breastfeed while receiving Trodelvy® and for some time after the last dose. The medicine may pass into breast milk and harm the baby. Patients should consult their doctor for guidance on when it is safe to resume breastfeeding.
  

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

What documents are required to import TRODELVY to India?

TRODELVY (sacituzumab govitecan-hziy) injection may be imported in the patient's name only, by patients or government hospitals. The following documentation is required:

• A valid prescription from a qualified doctor

• The patient's diagnostic reports

• Patient ID proof (issued by the Government of India)

How is the order confirmed? 

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit. 

Is TRODELVY available in India?

TRODELVY (sacituzumab govitecan-hziy injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, TRODELVY is not commercially marketed in India.

However, patients in India can legally access TRODELVY through the Named Patient Program (NPP) — an import provision that allows a medicine not yet registered in India to be imported in the name of an individual patient, on the prescription of their treating physician.

NamedPatientProgram.com (NPP) acts as a facilitator under named patient supply, providing input on: 

• Availability of Trodelvy in India and pathways to access it

• Availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE)

• Trodelvy price in India under the NPP route

• Sourcing from genuine, reliable channels in the USA, Canada, Europe, and Australia

• Ensuring full transparency throughout the process

TRODELVY can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others— and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.

NamedPatientProgram.com (NPP) can source Trodelvy from reliable global channels and facilitate supply to patients, doctors, and hospitals under applicable legal provisions. As a temperature-sensitive biologic, Trodelvy requires cold-chain handling throughout transit.

All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled. 

For Trodelvy cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.